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manufacture clinically relevant numbers of cells in an eco-
nomical and reproducible manner. For adherent cell types, the 
ideal culture system should comprise both a defi ned culture 
medium and a substrate that can be readily used with existing 
cultureware. 
 Commercially available defi ned media formulations have 
improved reproducibility of hPSC expansion by avoiding 
mouse embryonic fi broblast-conditioned medium, which 
remains commonplace but exhibits high batch variability. [ 9–11 ] 
Nonetheless, there is still widespread use of the poorly defi ned 
mouse sarcoma preparation, Matrigel, as a cell attachment sur-
face. [ 12 ] Such xenogenic components create a barrier to clinical 
translation as they face greater regulatory hurdles. Progress has 
been made with polymeric materials that can be easily manu-
factured from inexpensive, readily available monomers and are 
readily scalable industrially. [ 13 ] High throughput screening of 
polymer microarrays has identifi ed polymers as able to support 
the clonal growth of human embryonic stem cells (hESCs). [ 5 ] 
However, synthetic polymers identifi ed by screening to date 
require preconditioning with a protein for cell attachment and 
 Human pluripotent stem cells (hPSCs) are proving valuable 
for various biomedical applications due to their ability to self-
renew and be differentiated into numerous lineages representa-
tive of the three embryonic germ layers. [ 1–4 ] We apply a high 
throughput materials discovery approach to identify a novel 
polymer for hPSC culture using microarray screening of an 
unprecedented chemical space (141 monomers, polymerized 
alone and mixed to form 909 unique polymers, tested in 4356 
individual assays). This identifi ed the fi rst synthetic polymeric 
substrate that achieves both pluripotent hPSC expansion (in the 
commercially available culture media, StemPro and mTeSR1) 
and subsequent multilineage differentiation into representa-
tives of the three germ layers, namely cardiomyocytes, hepato-
cyte-like cells, and neural progenitors. A simple procedure was 
developed to coat standard cultureware with this polymer and 
notably, there was no need for protein preconditioning prior to 
use, which is a signifi cant advance on previous polymers dis-
covered by high throughput screening. [ 5–8 ] 
 For the signifi cant therapeutic potential of hPSCs to be real-
ized, bioprocessing-scale culture systems are required that can 
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pluripotent cell expansion, limiting their clinical and commer-
cial applicability. Furthermore, both pluripotent expansion of 
hPSCs and multilineage differentiation has not been demon-
strated on a single synthetic surface. 
 A multigeneration high throughput polymer microarray 
screening methodology incorporating high throughput surface 
characterization (HT-SC) was used to identify materials that can 
support the attachment and pluripotency of the HUES7 hESC 
line in the widely used commercial defi ned, serum- and feeder-
free medium, StemPro. [ 14 ] The fi rst-generation array, consisting 
of 141 monomers of wide chemical diversity (utilizing more 
than 90% of photo curable monomers that are readily com-
mercially available), was printed using metal pins to transfer 
the liquid monomers onto poly(2-hydroxyethyl methacrylate) 
(polyHEMA) coated glass slides as spots with six replicates 
of each homopolymer ( Figure  1 a – monomer structures pre-
sented in Figure S1 in the Supporting Information). [ 15 ] Polymer 
microarray spots of diameters ranging from 250 to 400 µm 
were formed by UV initiated photopolymerization using a 
modifi cation of methods described previously which reduced 
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 Figure 1.  Multigeneration microarray screening strategy and HT-SC. a) A fi rst-generation array of wide chemically diversity (utilizing more than 90% 
of photo curable monomers that are readily commercially available) was screened for hPSC attachment. b) Materials were ranked by OCT4 + hPSC 
attachment (six replicates) after 24 h in culture whereupon cells were quantifi ed by DAPI and OCT-4 staining c). d) Twenty-four “hit” materials were 
mixed pairwise (70/30% v/v) in a combinatorial manner to produce a second-generation of 576 unique materials which were assessed and ranked 
for OCT4 + hPSC attachment (e). f) Nine monomers were identifi ed that formed various hit copolymers in the second-generation array, these formed 
the third-generation array but were mixed in further ratios to form an array of 297 materials which were ranked by OCT4 + hPSC attachment to identify 
lead compositions for scale up (g). h) Chemical structure of the HPhMA monomer. i) XPS analysis of polyHPhMA, polyLMA, and copolymers thereof 
to determine the actual surface chemistry. Line is drawn to guide the eye. j,k) ToF-SIMS (j) and XPS (k) analysis of polyHPhMA in the third-generation 
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spreading of the large library of monomers on the polyHEMA 
substrate prior to UV irradiation (Figure S2, Supporting Infor-
mation). [ 16,17 ] Arrays were preconditioned for 1 h in StemPro 
medium prior to seeding with 1 × 10 6 HUES7 hESCs and cul-
turing for 24 h. Samples were fi xed, stained for OCT4 expres-
sion (an indicator of pluripotency) and images acquired using 
an automated fl uorescence microscope. Images were automati-
cally processed to quantify cell response to each polymer spot 
(using CellProfi ler software). This initial screen was used to 
identify 24 “hit” materials on the basis of their ability to sup-
port high HUES7 hESC attachment across six replicates whilst 
maintaining OCT4 expression (>90%) (Figure  1 b,c – “hit” 
monomer structures presented in Figure S3 in the Supporting 
Information). 
 To explore the effect of copolymerization the 24 hit mono-
mers were mixed pairwise (70/30% v/v mixtures to explore 
each monomer as a major and minor component of each 
copolymer) to form a second-generation array design com-
prising 576 unique materials in triplicate (Figure  1 d). Quan-
tifying OCT4 + HUES7 cell attachment after 24 h on the 
second-generation array in the same way as before identifi ed 
a refi ned list of nine monomers that displayed high hPSC 
attachment as homopolymers and copolymers across the array 
(up to 100 cells spot −1 ) (Figure  1 e). Synergistic combinations 
of monomers were noted, whereby greater hPSC attachment 
was observed for a copolymer than their homopolymer coun-
terparts. However, no clear copolymer candidate could be iden-
tifi ed to take forward for scale up purposes for hPSC expan-
sion. A third-generation array was used to explore hit mono-
mers as copolymers at varied composition ratios to determine 
whether substrates could be improved further for HUES7 cell 
attachment and maintenance of OCT4 expression during the 
fi rst 24 h of culture. Of the 24 monomers that were employed 
in the second-generation array, nine monomers were taken 
forward to the third-generation array as there were able to 
support high hPSC attachment as homopolymers and mul-
tiple copolymer formulations. The nine lead monomers were 
mixed combinatorially, utilizing additional ratios (10, 20, 30, 
and 40% v/v) to produce a third-generation array of 297 mate-
rials (Figure  1 f). To make the assay more stringent in order to 
identify the most robust candidate polymers, the cell seeding 
density was reduced. This led to a signifi cant reduction in cell 
attachment across the array, with only 90 copolymers showing 
signifi cant cell adhesion. 
 The best performing polymers in the third-generation 
array all contained monomer 5 ( N -(4-hydroxyphenyl)meth-
acrylamide) (HPhMA), which was able to support HUES7 
cell adhesion both as a homopolymer and as a copolymer 
(up to 56 ± 7 cells spot −1 ) (Figure  1 g). Inclusion of HPhMA 
as a minor component (10%–40% v/v) with monomers that 
performed poorly as homopolymers dramatically increased 
the performance of the resulting copolymers. For example, 
monomer 26 (lauryl methacrylate) (LMA) supported no attach-
ment of hPSCs across the array as a homopolymer. However, 
inclusion of HPhMA as a minor (10% v/v) or major (90% v/v) 
component with LMA increased hPSC attachment to 41 ± 15 
and 38 ± 9 cells spot −1 , respectively (Figure  1 g). To investigate 
the excellent cell attachment performance of HPhMA-con-
taining copolymers in the third-generation array, the intensity 
of the time-of-fl ight secondary-ion mass spectrometry (ToF-
SIMS) ions characteristic to HPhMA (C 7 H 4 NO 2 − ) and LMA 
(C 9 H 11 O 2 + ) were compared in the spectra of the homopolymers 
and copolymers using high throughput surface characteriza-
tion (Figure S4, Supporting Information). The intensity of 
the characteristic C 7 H 4 NO 2 − secondary ion was highest in the 
polyHPhMA homopolymer and decreased dramatically upon 
inclusion of LMA. This can be explained by the surface enrich-
ment of LMA, possibly in the monomer mixture prior to UV 
photopolymerization. The intensity of C 9 H 11 O 2 + secondary 
ion characteristic of LMA was consistent with this explana-
tion. To quantify the amount of HPhMA at the surface of these 
materials, X-ray photoelectron spectroscopy (XPS) analysis 
was employed using the elemental abundance of nitrogen as 
a marker for polyHPhMA (Figure  1 i). The relative amount 
of nitrogen in polyHPhMA homopolymer ([ N ] = 4 at%) was 
reduced by half upon inclusion of 10% LMA (1.9%). The 
amount of nitrogen in the XPS spectra follows a similar trend 
to the C 7 H 4 NO 2 − ion in the ToF-SIMS spectra for these mate-
rials confi rming that LMA was enriched at the surface. Despite 
there being relatively lower levels of polyHPhMA at the surface 
of all copolymers than the uniform distribution expected of sta-
tistical copolymers high cell attachment was achieved on these 
polymers, suggesting that only small amounts of HPhMA are 
required to encourage cell attachment. Moreover, copolymer 
formulations did not signifi cantly increase cell attachment over 
polyHPhMA. Therefore, our detailed analysis showed that the 
benefi ts of using a copolymer were modest on hPSC attach-
ment and did not outweigh the added complexity of fabrication, 
analysis, and quality control relative to using a homopoly mer. 
This meant we elected to take forward polyHPhMA for hPSC 
expansion studies. 
 Scaling up of polyHPhMA into six-well plates was achieved 
(see methods) and analyzed by ToF-SIMS to determine if the 
surface chemistry was consistent with polyHPhMA in micro-
array spots. ToF-SIMS peaks characteristic of HPhMA were 
observed at  m / z = 108 and 109 (C 6 H 6 NO + and C 6 H 7 O + , respec-
tively) from both microarray spots and from coatings scaled 
up to coat six-well plates (Figure  1 j). Although the polyHEMA 
substrate was used throughout the array screening process, we 
observed additional peaks at  m / z = 45 and 113 (C 2 H 5 O + and 
C 6 H 9 O 2 + , respectively) only in the third-generation polymer 
microarray (likely due to thinner spots than previous genera-
tion arrays), which are characteristic of the polyHEMA slide 
coating indicating it had intermixed with the deposited mono-
mers and was present at the surface of the spots of this array. 
 Transparent coatings of polyHPhMA were achieved by 
presynthesizing the polymer and dissolving in ethanol before 
casting onto plasma etched tissue culture polystyrene (PE-
TCPS) cultureware. Cracking within the coating of polyHPhMA 
was observed upon storage in cell culture incubators. The 
serendipitous discovery of the benefi cial role of polyHEMA 
within polyHPhMA in the micro array format was utilized in 
the scaled up well plate experiments by conventional copoly-
merization of the two monomers (Figure  1 h,l). Poly(HPhMA-
 co -HEMA) gave transparent coatings that did not crack, even 
after 1 month of incubation in medium. XPS analysis of 
poly(HPhMA- co -HEMA) coatings confi rmed the composition of 
the material (Figure  1 k). 
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 To evaluate hPSC expansion on these substrates we fi rst 
assessed whether preconditioning with culture medium or 
ECM proteins was required for hPSCs to retain pluripotency 
in six-well plates coated with poly(HPhMA- co -HEMA). Attach-
ment and distribution of hPSCs 24 h after seeding in StemPro 
was similar irrespective of preconditioning, as was the time 
required to reach confl uency (72 h). Therefore, precondi-
tioning was omitted in subsequent experiments. This approach 
enabled cells to be cultured through fi ve serial passages with 
accutase on the poly(HPhMA- co -HEMA) substrate maintaining 
expression of OCT4, TRA181, and SSEA4 in >93% cells, as 
measured by quantitative immunofl uorescence using an auto-
mated plate reader (Operetta) and high-content image analysis 
software (CellProfi ler), with retention of a 46,XY karyotype 
by G-banding 30 cells ( Figures  2 a,b and S5, Supporting 
Information). 
 We next sought to explore whether the poly(HPhMA- co -
HEMA) substrate could support pluripotent expansion of 
hESC and hiPSC lines in different commercial culture media. 
Thus, cultures of the HUES7 hESC line and BT1 hiPSC line 
were initiated in StemPro and another commonly used defi ned 
medium, mTeSR1. [ 9 ] In each case the conditions supported pro-
liferation through fi ve serial passages, whilst retaining stable 
karyotype (46,XY for HUES7; 46,XX for BT1) (Figure S5, Sup-
porting Information), and pluripotent marker expression of 
OCT4, TRA181, and SSEA4 by immunofl uorescence (all >88%) 
(Figure  2 a,b). Repeat experiments conducted on poly(HPhMA-
 co -HEMA)-coated cultureware stored for at least 6 months at 
Adv. Mater. 2015, 27, 4006–4012
www.advmat.de
www.MaterialsViews.com
 Figure 2.  hPSC expansion through serial passage. a) Positive immunofl uorescence for pluripotent markers OCT4, TRA181, and SSEA4 following serial 
passaging of hPSCs on poly(HPhMA- co -HEMA). Scale bar = 50 µm. b) hPSCs on poly(HPhMA- co -HEMA) maintain pluripotent marker expression 
levels, with OCT4, TRA181, and SSEA4 expression >88%. hESCs adhered to poly(HPhMA- co -HEMA) actively express the integrins c) β 1 and d) α V β 5 . 
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ambient conditions produced identical results, demonstrating 
that these coatings can be used off-the-shelf in the same way as 
general TCPS cultureware. 
 To determine a mechanism for the hPSC adhesion to 
poly(HPhMA- co -HEMA), antibody blocking assays were per-
formed for key hPSC integrins. Blocking of the integrins β 1 
and α V β 5 resulted in a signifi cant reduction (>30%) in hPSC 
attachment to poly(HPhMA- co -HEMA) when cultured in 
StemPro media (Figure  2 c–e). Although hPSCs have been 
shown to express numerous integrins, including those of the 
α 1 , α 2 , α 3 , α 5 , α 6 , α 7 , α V , and α 11 , and β 1 , β 2 , β 3 , and β 5 fami-
lies, only α 2 , α 5 , α 6 , α V , and β 1 integrins have been shown to 
play a signifi cant role in hPSCs adhesion to Matrigel coated 
culture surfaces and only α V integrins in hPSC adhesion to 
polymer culture surfaces without matrix coatings. [ 5,12,18–21 ] 
This is therefore the fi rst report demonstrating a role for β 1 
as well as α V integrins in hPSCs adhesion to polymer culture 
surfaces without matrix coatings. Although individually α V β 5 
binds vitronectin sites and β 1 binds fi bronectin and laminin 
sites, it is likely that these two integrins interact in a complex 
manner to promote hPSC adhesion to sites present in the 
poly(HPhMA- co -HEMA) chemistry or to proteins adsorbed 
from the medium. [ 22 ] 
 Differentiation capacity would greatly increase the utility of 
expansion culture substrates. We, therefore, sought to evaluate 
whether the formation of representatives of each of the three 
Adv. Mater. 2015, 27, 4006–4012
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 Figure 3.  Three germ layer directed differentiation of hPSCs on polymeric substrate. a) Mesoderm differentiation on poly(HPhMA- co -HEMA) induced 
positive α-actinin and cardiac troponin-T expression of similar levels as cells induced on a Matrigel control surface. Scale bar = 50 µm. b) Electrophysi-
ology of the spontaneously beating cardiomyocytes on poly(HPhMA- co -HEMA) showed all subtypes of cardiomyocytes, c) with a mean APD of 417 ± 
102 ms. d) Endoderm differentiation on poly(HPhMA- co -HEMA) induced hepatic marker expression in hepatocyte-like cells with positive endoderm 
expression (scale bar = 100 µm) and active AFP secretion e). f) Ectoderm differentiation on poly(HPhMA- co -HEMA) induced neurogenesis marker 
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germ layers during human development could be induced by 
directing differentiation on poly(HPhMA- co -HEMA). 
 We directed formation of cardiomyocytes (mesoderm) by 
culturing 2D monolayers of hPSCs on poly(HPhMA- co -HEMA) 
with modulators of the transforming growth factor beta (TGF-β) 
superfamily (activin A and BMP4) and WNT (KY02111 and 
XAV393) pathways. [ 23 ] In the same time course as hPSCs differ-
entiated on Matrigel (12 d), beating clusters of cardiomyocytes 
spontaneously formed (see Video S1 in the Supporting Infor-
mation), which were shown by immunostaining to be positive 
for α-actinin and cardiac troponin-T staining ( Figure  3 a). Func-
tional analysis of the differentiated cells by patch clamp showed 
they had electrophysiological characteristics similar to those pre-
viously published for hPSC-cardiomyocytes, including a mean 
action potential duration (APD) of 417 + 102 ms (Figure  3 b). [ 24 ] 
Based on 90%/50% repolarization values (APD90/APD50), 
these cultures contained ventricular (APD90/APD50 of ≤1.3), 
atrial (≥1.8), and pacemaker (1.4–1.7) cardiomyocyte subtypes 
(Figure  3 c). [ 25 ] 
 Directed hepatocyte differentiation (endoderm) was achieved 
via an 18 d protocol using activin-A, Wnt3a, FGF, HGF, and 
oncostatin-M to modulate signaling cascades. [ 26 ] Differenti-
ated cell cultures on poly(HPhMA- co -HEMA)-coated substrates 
expressed albumin, AFP, HNF4A, and A1AT and secreted 
AFP with comparable effi ciency to Matrigel-coated controls 
(Figure  3 d,e). 
 Finally, we induced hPSC differentiation to neural progeni-
tors, which arise from the ectoderm germ layer. Dual SMAD-
inhibition with dorsomorphin and SB431542 for 7 d induced 
the formation of neural rosette-like colonies on poly(HPhMA-
 co -HEMA) substrates (Figure  3 f). [ 27,28 ] Neural progenitors 
produced on Matrigel and poly(HPhMA- co -HEMA) displayed 
similar levels of PAX6 and SOX1 markers (PAX6: 78% ± 
4% and 74% ± 8%; SOX1: 68% ± 11% and 69% ± 18%, 
respectively). 
 In summary, we have used a high throughput combinato-
rial approach to identify and develop a defi ned, synthetic poly-
meric substrate that supports hPSC pluripotency and expan-
sion through serial passage in commercial defi ned media 
without the need for protein pre-adsorption. This was achieved 
for both hESCs and hiPSCs. Additionally, directed differentia-
tion was achieved on the hit polymer, poly(HPhMA- co -HEMA), 
to representatives of each of the three germ layers, including 
spontaneous beating clusters of cardiomyocytes (mesoderm), 
hepatocyte-like cells (endoderm), and neuro-ectoderm (ecto-
derm). It is proposed that the compatibility of this substrate 
with pluripotent cell expansion is consistent with the ready dif-
ferentiation of these cells under the infl uence of soluble factors. 
Thus, poly(HPhMA- co -HEMA) fulfi lls all the current culture 
requirements for the clinical use of stem cells within regenera-
tive medicine and can be scaled up by coating onto cultureware 
to be used off-the-shelf, providing a cost-effective alternative to 
commercially available hPSC expansion substrates. The expan-
sion of hPSCs and production of terminally differentiated cell 
types without the infl uence of undefi ned and xenogenic matrix 
protein coatings provides a robust platform for the industrial 
scale production of hPSCs for regenerative medicine applica-
tions and therapies. 
 Experimental Section 
 Preparation of Polymers : polyHPhMA and poly(HPhMA- co -HEMA) 
were prepared via a thermally initiated free radical polymerization in an 
ethanolic solution with the addition of 2,2′-azobis(2-methylpropionitrile) 
(AIBN—1% w/w to HPhMA). The isolated and dried polymers were 
dissolved in ethanol (5% w/v) and added into TCPS six-well to cover 
the base of each well plate directly after oxygen plasma activation. 
The solvent was allowed to evaporate under ambient conditions for 
24 h prior to hPSC culture. Complete detailed methodology of polymer 
synthesis, characterization, and all cell culture protocols can be found in 
the Supporting Information. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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